dexmedetomidine has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Fu, C; Qiu, F; Wang, M; Zhang, K | 1 |
Gaafary, ME; Hafner, S; Huber, R; Lang, SJ; Paetz, C; Schmidt, CQ; Schmiech, M; Simmet, T; Steinborn, C; Syrovets, T; Werner, K | 1 |
Jun, JH; Kim, KS; Kwak, YL; Oh, JE; Shim, JK; Soh, S | 1 |
Ai, D; Banchs, J; Cata, JP; Feng, L; Vaporciyan, AA; Xu, G; Yu, J | 1 |
Cata, JP; Feng, L; Moon, T; Peng, SP; Tsai, JY; Vachhani, S; Vaporciyan, AA | 1 |
5 other study(ies) available for dexmedetomidine and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Casticin and chrysosplenol D from Artemisia annua L. induce apoptosis by inhibiting topoisomerase IIα in human non-small-cell lung cancer cells.
Topics: Apoptosis; Artemisia annua; Carcinoma, Non-Small-Cell Lung; DNA Topoisomerases, Type II; Flavones; Flavonoids; Humans; Lung Neoplasms; Molecular Docking Simulation | 2022 |
Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisia annua; Artemisinins; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Female; Flavones; Flavonoids; Humans; Leukocytes, Mononuclear; Lung Neoplasms; Mice; Mice, Nude; Plant Extracts; Xenograft Model Antitumor Assays | 2019 |
Effects of dexmedetomidine on A549 non-small cell lung cancer growth in a clinically relevant surgical xenograft model.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Dexmedetomidine; Heterografts; Humans; Inflammasomes; Inflammation; Interleukin-10; Interleukin-18; Lung Neoplasms; Mice; Mice, Nude; NLR Family, Pyrin Domain-Containing 3 Protein | 2023 |
Dexmedetomidine does not reduce atrial fibrillation after lung cancer surgery.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Atrial Fibrillation; Carcinoma, Non-Small-Cell Lung; Dexmedetomidine; Female; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Pulmonary Surgical Procedures; Retrospective Studies; Treatment Outcome | 2015 |
The Use of Intraoperative Dexmedetomidine Is Not Associated With a Reduction in Acute Kidney Injury After Lung Cancer Surgery.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dexmedetomidine; Female; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Pulmonary Surgical Procedures; Retrospective Studies; Risk Factors; Young Adult | 2016 |